These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2660346)

  • 1. A controlled trial of dipyridamole as an immunomodulator in renal allograft recipients.
    Niyamathullah MM; Hariharan S; Jacob CK; Pandey AP; Gopalakrishnan G; Date A; Shastry JC; Kirubakaran MG
    Transplantation; 1989 Jun; 47(6):1071-2. PubMed ID: 2660346
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
    Anderson M; Dewar P; Fleming LB; Hacking PM; Morley AR; Murray S; Swinney J; Taylor RM; Uldall PR; Wardle EN
    Clin Nephrol; 1974; 2(3):93-9. PubMed ID: 4603996
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of dipyridamole on the results of allogenic kidney transplantation].
    Schulze R; Langkopf B; Sziegoleit W
    Z Urol Nephrol; 1990 May; 83(5):255-9. PubMed ID: 2203215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of vascular graft lesions in renal transplant recipients with a new antithrombotic agent (defibrotide): a controlled study.
    Frascà GM; Vangelista A; Raimondi C; Bonomini V
    Life Support Syst; 1986; 4(3):231-7. PubMed ID: 3537545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of defibrotide in renal transplantation in man.
    Bonomini V; Vangelista A; Stefoni S; Scolari MP; Frascà GM; Raimondi C
    Haemostasis; 1986; 16 Suppl 1():48-50. PubMed ID: 3519383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts.
    Mathew TH; Clyne DH; Nanra RS; Kincaid-Smith P; Saker BM; Morris PJ; Marshall VC
    Lancet; 1974 Jun; 1(7870):1307-10. PubMed ID: 4134294
    [No Abstract]   [Full Text] [Related]  

  • 7. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction.
    Delmonico FL; Auchincloss H; Rubin RH; Russell PS; Tolkoff-Rubin N; Fang LT; Cosimi AB
    Ann Surg; 1987 Nov; 206(5):649-54. PubMed ID: 3314751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of methylprednisolone on first renal allograft rejection.
    Ahonen J; Häyry P; von Willebrand E; Eklund B; Lindström BL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):328-31. PubMed ID: 7022846
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High- versus low-dose methylprednisolone for acute rejection episodes in renal transplantation.
    Park GD; Bartucci M; Smith MC
    Nephron; 1984; 36(2):80-3. PubMed ID: 6363949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy.
    Lui SF; Sweny P; Scoble JE; Varghese Z; Moorhead JF; Fernando ON
    Nephrol Dial Transplant; 1989; 4(5):387-9. PubMed ID: 2505189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pretransplant erythropoietin therapy on renal allograft outcome.
    Vasquez EM; Pollak R
    Transplantation; 1996 Oct; 62(7):1026-8. PubMed ID: 8878400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft irradiation in the treatment of acute rejection of renal transplants: a randomized study.
    Pilepich MV; Anderson CB; Etheredge EE; Sicard GA; Melzer JS; Blum J
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):823-7. PubMed ID: 7050047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
    Bell PR; Blamey RW; Briggs JD; Castro JE; Hamilton DN; Knapp MS; Salaman JR; Sells RA; Williams G; Gowans JL; Peto R; Richards S; Phillips AW; Weinberg AL; Freestone DS
    Transplantation; 1983 Jun; 35(6):539-45. PubMed ID: 6346595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of transplant renal artery stenosis.
    Kauffman HM; Sampson D; Fox PS; Doyle TJ; Maddison FE
    Surgery; 1977 Feb; 81(2):161-7. PubMed ID: 319550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Hesse UJ; Fryd DS; Chatterjee SN; Simmons RL; Sutherland DE; Najarian JS
    Arch Surg; 1986 Sep; 121(9):1056-60. PubMed ID: 3527111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
    Mathew TH; Hogan GP; Lewers DT; Bauer H; Maher JF; Schreiner GE
    Transplant Proc; 1971 Mar; 3(1):901-4. PubMed ID: 4937989
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of chronic kidney allograft rejection by cyclosporine.
    Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Zerati-Filho M; Verona CB; Martucci RC; Bezas AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1660-2. PubMed ID: 2652544
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
    George CR; Slichter SJ; Quadracci LJ; Kenny GM; Dennis MB; Striker GE; Harker LA
    Transplantation; 1975 Sep; 20(3):237-40. PubMed ID: 1099729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial.
    Papadakis J; Brown CB; Cameron JS; Adu D; Bewick M; Donaghey R; Ogg CS; Rudge C; Williams DG; Taube D
    Br Med J (Clin Res Ed); 1983 Apr; 286(6371):1097-100. PubMed ID: 6404341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.